D-Wave Quantum: A Federal Lifeline That Arrived With Strings Attached

D-Wave's $100M CHIPS Act deal brings a share overhang, securities probes and an interim CFO, as the stock falls 38% year-to-date.

Washington's backing was supposed to be the moment D-Wave Quantum turned the corner. Instead, the deal has handed the quantum computing specialist a fresh set of headaches — a looming share overhang, a legal cloud, and a leadership vacuum in the finance department, all arriving at once.

Up to $100 million is flowing to the company through the CHIPS and Science Act, earmarked for research into superconducting annealing and gate-model technologies. In return, the US Department of Commerce secured a non-controlling minority stake. What looked like vindication on paper has proven considerably messier in practice.

The fine print behind the federal cheque

The mechanics of the arrangement are what unsettle existing shareholders. To establish its position, the Commerce Department received 7,095,721 newly issued common shares. D-Wave then filed a prospectus supplement under its Form S-3ASR shelf registration to facilitate a potential resale of those shares by the department — a filing accompanied by a legal opinion from the law firm Paul, Weiss.

That structure matters. When Washington can sell into the open market, investors reasonably brace for dilution and sustained selling pressure. The grant money may be earmarked for semiconductor process technology and the advancement of superconducting quantum architectures, but the equity side of the bargain leaves a far more immediate impression on the tape.

Legal scrutiny adds to the weight

Compounding the overhang, several US law firms announced last Thursday that they are investigating possible securities law violations. The inquiries target the company's recent business figures as well as the share issuance tied to the federal funding.

Such probes are close to routine for volatile US-listed names, yet they still consume management bandwidth and inject additional uncertainty. The stock came under renewed pressure during the session, changing hands at EUR 13.98, down 3.5 percent. On Monday it slipped 1.9 percent to EUR 14.21.

Operational progress cuts both ways

Strip away the noise and the second-quarter 2026 operating picture is genuinely mixed. On the commercial front, the company made notable strides: commercial customers generated 62.4 percent of quarterly revenue, while subscription revenue from quantum-computing-as-a-service climbed 50 percent to $1.9 million. Bookings were the standout, multiplying by 1,120 percent in the first half, with remaining performance obligations rising to $40.7 million.

Those percentages flatter a small base, however. With revenue still in the low single-digit millions, advancing quantum hardware continues to devour enormous sums. The absolute figures offer little cushion against the structural fragility that persists beneath the growth rates.

A changing of the guard in finance

Personnel adds another wrinkle. Long-serving CFO John Markovich retired on September 2, roughly two weeks after the company disclosed his departure. Greg Golkov, previously Senior Vice President of Finance, stepped in as interim CFO and principal financial and accounting officer.

The timing is awkward. Integrating federal funds and fending off legal allegations is demanding work under any circumstances; doing it with a transitional finance chief at the helm hardly inspires confidence.

What the smart money is doing

Not everyone is heading for the exits. Institutional buying — including The Manufacturers Life Insurance Company of Canada taking a position of about 204,727 shares — suggests some large holders retain a baseline of faith. The US government, for its part, is committing $300 million across the sector, split between D-Wave and rivals Rigetti Computing and Quantinuum, underscoring the geopolitical stakes attached to quantum technology.

Yet the warning signs currently outweigh the endorsements. Down 38 percent since the start of the year — with one source putting the year-to-date decline at 37 percent — the share price reflects mounting investor skepticism.

Until the legal questions are resolved and the market absorbs the government's additional stock, a durable recovery looks blocked. Technological breakthroughs alone rarely carry a stock when the capital structure and investor trust are wobbling at the same time.